TIDMTYR TIDMTYRU

RNS Number : 3546I

TyraTech, Inc.

25 March 2015

TyraTech, Inc.

("TyraTech" or the "Company")

Vamousse(R) head lice treatment now distributed by CVS in the USA

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is pleased to announce that it has secured listings for its Vamousse Treatment product with the CVS Pharmacy Group in the USA.

CVS Pharmacy

CVS Pharmacy is the second largest pharmacy chain after Walgreens in the United States, with more than 7,600 stores and 100 million American customers each year. This listing, which follows the recent announcement of deals with the top three pharmaceutical distributors in the USA, represents a further key milestone for the roll-out of TyraTech's Vamousse products in America. It is expected that the Treatment product will be available in the majority of CVS stores nationwide in the USA from the end of April 2015.

Tesco update

In addition to the progress in the USA, we are pleased to announce positive developments in our UK distribution network also. Tesco, which had until recently been selling the Vamousse Treatment product through its pharmacy counters, will also place the product into open shelving, making it more accessible and visible to customers. Tesco has also confirmed separately, that it will almost double the number of stores stocking TyraTech's Vamousse Treatment product.

Bruno Jactel, Chief Executive Officer, said: "The CVS listing is probably our most important milestone this year as it firmly establishes our product in the pharmacy segment in the USA and significantly enhances the profile of our brand. I would like to thank our partner, the Greenwood Group, which has been instrumental in establishing the commercial relationship with CVS and our retail partners in the USA. Together with the recent announcement of the three biggest pharmaceutical distributors in the USA, and Lloyds and Day Lewis in the UK, we are very excited by the growth opportunities presented by the continually expanding distribution network for Vamousse products."

Further information on Vamousse(R) is available on the Company's website at http://www.vamousselice.com/

 
 TyraTech Inc. 
  Bruno Jactel, Chief Executive       Tel: +1 919 
  Officer                             415 4340 
  Vince Morgus, Chief Financial       Tel: +1 919 
  Officer & Treasurer                 415 4287 
 SPARK Advisory Partners Limited,   Tel: +44203 
  Nominated Adviser                  368 3552 
  Matt Davis / Mark Brady            Tel: +44203 
                                     368 3551 
 Allenby Capital Limited , 
  Joint Broker                        Tel: +44 20 
  Chris Crawford                      3328 5656 
 Whitman Howard Limited, Joint 
  Broker                              Tel: +44 20 
  Ranald Mc-Gregor Smith /            7659 1240 
  Niall Devins 
 Walbrook, Financial PR and 
  IR                                  Tel: +44 20 
  Nick Rome /Guy McDougall            7933 8790

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCBLGDXSSDBGUS

Tyratech (LSE:TYR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Tyratech Charts.
Tyratech (LSE:TYR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Tyratech Charts.